Floatz logo

Bushen Culuan Decoction

Hyperprolactinemia

Xiyuan Hospital of China Academy of Chinese Medical SciencesPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Hyperprolactinemia cohort.

Asset / SponsorPhaseRating
Risperdal
Si Tianmei
Phase 4BB
Paliperidone Palmitate 3-Month Formulation
Si Tianmei
Phase 4BB
Bromocriptin
University Hospital, Bonn
Phase 3B
Gnrh
Massachusetts General Hospital
Phase 1CC
Kisspeptin 112-121
Massachusetts General Hospital
Phase 1CC
Metformin
Taipei Medical University Hospital
N/AD

Same molecule, other indications

Bushen Culuan Decoction is also rated in:

polycystic ovary syndromeDormant
CCC
Indicative ·
53 / 100
View asset →
Luteinized Unruptured Follicle SyndromeDormant
CCC
Indicative ·
53 / 100
View asset →
Corpus Luteum InsufficiencyDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →